Bio-Works Technologies AB (XSAT:BIOWKS) Margin of Safety % (DCF FCF Based): N/A (As of Aug. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSAT:BIOWKS Bio-Works Technologies AB XSAT:BIOWKS
68 GF Score
Price kr3.40
GF Value kr3.62
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Bio-Works Technologies AB Margin of Safety % (DCF FCF Based)?

Margin of Safety % (DCF FCF Based) = (Intrinsic Value: DCF (FCF Based) - Current Price) / Intrinsic Value: DCF (FCF Based).

Note: Discounted FCF model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Bio-Works Technologies AB's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF FCF Based) is not calculated.

XSAT:BIOWKS vs ISRG, BDX, MDLN: Margin of Safety % (DCF FCF Based) Comparison

For the Medical Instruments & Supplies subindustry, Bio-Works Technologies AB's Margin of Safety % (DCF FCF Based), along with its competitors' market caps and Margin of Safety % (DCF FCF Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bio-Works Technologies AB Margin of Safety % (DCF FCF Based) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Bio-Works Technologies AB's Margin of Safety % (DCF FCF Based) distribution charts can be found below:

* The bar in red indicates where Bio-Works Technologies AB's Margin of Safety % (DCF FCF Based) falls into.


XSAT:BIOWKS
68GF Score
Bio-Works Technologies AB XSAT:BIOWKS
Margin of Safety % (DCF FCF Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Bio-Works Technologies AB (XSAT:BIOWKS) Overvalued in 2026?

Based on GuruFocus' analysis, Bio-Works Technologies AB stock appears to be undervalued. The current stock price of kr3.40 is trading 6.1% below its estimated GF Value™ of kr3.62. GuruFocus considers Bio-Works Technologies AB to be Fairly Valued.

Key valuation signals for XSAT:BIOWKS:

  • Margin of Safety % (DCF FCF Based): N/A
  • GF Value™: kr3.62 vs. price of kr3.40 (6.1% below fair value)
  • GF Score™: 68/100 with 2 warning signs

No single metric tells the full story. See the XSAT:BIOWKS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bio-Works Technologies AB Business Description

Other Exchanges 1BD:Germany
Address Virdings alle 18, Uppsala, SWE, 75450
Bio-Works Technologies AB is a Sweden-based life science company which is engaged in designing, developing, manufacturing and supplying products for purification and separation of proteins and other molecules. The product line of the company includes activated resin, immobilized metal-ion affinity chromatography resin, ion exchange chromatography resin, size exclusion chromatography resin and others. The company has also developed affinity chromatography technique, BabyBio Columns, OptiBio glass columns for separating proteins, and protein purification. Bio-Works serves various end users such as academic research laboratories, biopharmaceutical companies, the food and beverage industry and others.
68GF Score

Get the complete analysis for XSAT:BIOWKS

Margin of Safety % (DCF FCF Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr3.40
Price
kr3.62
GF Value